Synonym
Eprozinol dihydrochloride
IUPAC/Chemical Name
1-Piperazinepropanol, 4-(beta-methoxyphenethyl)-alpha-phenyl-, dihydrochloride
InChi Key
KVKUGOLSESPAPP-UHFFFAOYSA-N
InChi Code
InChI=1S/C22H30N2O2.2ClH/c1-26-22(20-10-6-3-7-11-20)18-24-16-14-23(15-17-24)13-12-21(25)19-8-4-2-5-9-19;;/h2-11,21-22,25H,12-18H2,1H3;2*1H
SMILES Code
OC(C1=CC=CC=C1)CCN2CCN(CC(OC)C3=CC=CC=C3)CC2.[H]Cl.[H]Cl
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
427.41
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Merigot P, Garnier R, Efthymiou ML. [Convulsions with 3 antitussive substituted derivatives of piperazine (zipeprol, eprazinone, eprozinol)]. Ann Pediatr (Paris). 1985 Jun;32(6):504-6, 511. French. PubMed PMID: 4026148.
2: Labrid C, Duchene-Marullaz P, Rispat G. Mechanisms of anti-bronchoconstrictive effects of eprozinol. II. In vivo studies on the guinea pig. Pharmacology. 1981;23(1):48-55. PubMed PMID: 7312935.
3: Labrid C, Burtin C, Stoclet JC, Dureng G, Schoeffter P, Lebel B, Duchene-Marullaz P. Mechanisms of anti-bronchoconstrictive effects of eprozinol. I. In vitro studies. Pharmacology. 1981;23(1):31-47. PubMed PMID: 6171839.
4: Nicrosini F, Carpinella G. [Eprozinol treatment of chronic bronchitis with dyspnea and cough]. Bronchopneumologie. 1978 Jul-Aug;28(4):322-7. French. PubMed PMID: 756799.
5: Labrid C, Dureng G, Duchene-Marullaz P, Moleyre J. Dualist or pseudo-dualist interactions of mepyramine, diphenhydramine and eprozinol with histamine at H1-receptors. Jpn J Pharmacol. 1977 Aug;27(4):491-500. PubMed PMID: 21982.
6: Duchene-Marullaz P, Rispat G, Perriere JP. [Several antihistaminic pharmacodynamic aspects, especially of Eprozinol]. Therapie. 1971 Jan-Feb;26(1):155-62. French. PubMed PMID: 4396627.